Literature DB >> 27485124

Anteroposterior translation and range of motion after total knee arthroplasty using posterior cruciate ligament-retaining versus posterior cruciate ligament-substituting prostheses.

Yoshinori Ishii1, Hideo Noguchi2, Junko Sato2, Tetsuya Sakurai2, Shin-Ichi Toyabe3.   

Abstract

PURPOSE: It is still controversial whether anteroposterior (AP) translation magnitude after total knee arthroplasty (TKA) affects clinical outcomes, particularly range of motion (ROM). This study examined the following two questions: (1) are AP translations at the mid- and long-term follow-up different for knees within the same patient treated with posterior cruciate ligament-retaining (PCLR) versus posterior cruciate ligament-substituting (PCLS) mobile-bearing TKA prosthesis designs? (2) Is the ROM at the mid- and long-term follow-up for knees treated with PCLR and PCLS designs correlated with the AP translation?
METHODS: Thirty-seven patients undergoing sequential bilateral TKA for osteoarthritis were prospectively enrolled. Patients received a PCLR implant in one knee and a PCLS implant in the other and were followed-up for an average 9.8 ± 3.2 years. The AP translations at 30° and 75° of knee flexion and the ROM of both knees were assessed.
RESULTS: The implant design (p < 0.001), but not flexion angle (n.s.), had a significant effect on AP translation. AP translation values were larger in PCLR knees than in PCLS knees at both flexion angles (p < 0.0001). The ROM at the final follow-up in the two implant designs was similar (both 115°, n.s.). There was a weak correlation between ROM and AP translation at 30° in the PCLR knees (r = 0.397, p = 0.015), but no correlation at 75° or in the PCLS knees.
CONCLUSIONS: Differently constrained prosthesis designs resulted in significantly different AP translational values within the same patient. This indicates that achieving good clinical outcomes and ROM after TKA may not be strongly influenced by the specifics of each patient's anatomical characteristics, but instead by knee constrainment. Clinically, this means that surgeons should familiarize themselves with the AP translation of the implant being used, as this may be the most important factor for optimizing outcomes after mobile-bearing TKA. Level of evidence II, prospective, comparative study.

Entities:  

Keywords:  Anteroposterior translation; Bilateral total knee arthroplasty (TKA); Mid- and long-term follow-up; Posterior cruciate ligament-retaining mobile-bearing TKA; Posterior cruciate ligament-substituting mobile-bearing TKA; Range of motion

Mesh:

Year:  2016        PMID: 27485124     DOI: 10.1007/s00167-016-4257-0

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  26 in total

1.  Laxity in posterior cruciate sparing and posterior stabilized total knee prostheses.

Authors:  D Dejour; G Deschamps; L Garotta; H Dejour
Journal:  Clin Orthop Relat Res       Date:  1999-07       Impact factor: 4.176

2.  In vivo laxity of low contact stress mobile-bearing prostheses.

Authors:  Yoshikazu Matsuda; Yoshinori Ishii
Journal:  Clin Orthop Relat Res       Date:  2004-02       Impact factor: 4.176

3.  The effect of anteroposterior laxity on the range of movement and knee function following a cruciate-retaining total knee replacement.

Authors:  J K Seon; S J Park; T R Yoon; K B Lee; E S Moon; E K Song
Journal:  J Bone Joint Surg Br       Date:  2010-08

4.  Anteroposterior stability in posterior cruciate ligament-retaining total knee arthroplasty.

Authors:  Hideki Mizu-Uchi; Shuichi Matsuda; Hiromasa Miura; Ryotaro Nabeyama; Ken Okazaki; Yukihide Iwamoto
Journal:  J Arthroplasty       Date:  2006-06       Impact factor: 4.757

5.  The effect of sagittal laxity on function after posterior cruciate-retaining total knee replacement.

Authors:  David P Gwynne Jones; Conlin Locke; Jonathon Pennington; Jean-Claude Theis
Journal:  J Arthroplasty       Date:  2006-08       Impact factor: 4.757

6.  Anteroposterior stability after posterior cruciate-retaining total knee arthroplasty.

Authors:  A J Schuster; A L von Roll; D Pfluger; T Wyss
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-01-14       Impact factor: 4.342

7.  Does mobile-bearing knee arthroplasty motion change with activity?

Authors:  Yoshinori Mikashima; Yoshinori Ishii; Mitsuhiro Takeda; Hideo Noguchi; Shigeki Momohara; Scott A Banks
Journal:  Knee       Date:  2013-09-05       Impact factor: 2.199

8.  Laxity and function in knee replacements. A comparative study of three prosthetic designs.

Authors:  P J Warren; T K Olanlokun; A G Cobb; P S Walker; B F Iverson
Journal:  Clin Orthop Relat Res       Date:  1994-08       Impact factor: 4.176

9.  Sagittal laxity after posterior cruciate ligament-retaining mobile-bearing total knee arthroplasty.

Authors:  Julien Chouteau; Jean Luc Lerat; Rodolph Testa; Bernard Moyen; Scott A Banks; Banks A Scott
Journal:  J Arthroplasty       Date:  2008-08-12       Impact factor: 4.757

10.  Implications of muscular defense in testing for the anterior drawer sign in the knee. A stress radiographic investigation.

Authors:  B F Iversen; J Stürup; K Jacobsen; J Andersen
Journal:  Am J Sports Med       Date:  1989 May-Jun       Impact factor: 6.202

View more
  2 in total

1.  [Effectiveness comparison of partial versus intact posterior cruciate ligament-retaining in total knee arthroplasty with cruciate-retaining prosthesis].

Authors:  Bo Zhang; Yuan Lin; Shixiang Ren; Tong Chen; Xiaoxiong Zhao; Yang Yu
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-01-15

2.  Comparison of Biomechanical Gait Parameters and Patient-Reported Outcome in Patients After Total Knee Arthroplasty With the Use of Fixed-Bearing Medial Pivot and Multi-radius Design Implants-Retrospective Matched-Cohort Study.

Authors:  Artur Stolarczyk; Bartosz M Maciąg; Marcin Mostowy; Grzegorz J Maciąg; Piotr Stępiński; Jakub Szymczak; Krystian Żarnovsky; Maciej Świercz; Łukasz Oleksy; Magda Stolarczyk
Journal:  Arthroplast Today       Date:  2022-01-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.